1 - 25 of
277
results
for author:"Yamamoto S."
in Literature Citations
| D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. Nishio Y., Makiyama T., Itoh H., Sakaguchi T., Ohno S., Gong Y.Z., Yamamoto S., Ozawa T., Ding W.G., Toyoda F. et al. J. Am. Coll. Cardiol. 54:812-819(2009) · Mapped (7) |
| Genetic diversity of gamma-hexachlorocyclohexane-degrading sphingomonads isolated from a single experimental field. Yamamoto S., Otsuka S., Murakami Y., Nishiyama M., Senoo K. Lett. Appl. Microbiol. 49:472-477(2009) · UniProtKB (35) |
| DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer. Yamashita S., Chujo M., Moroga T., Anami K., Tokuishi K., Miyawaki M., Kawano Y., Takeno S., Yamamoto S., Kawahara K. Anticancer Res. 29:2753-2757(2009) · Mapped (1) |
| Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species. Sato K., Yamamoto S.P., Misawa N., Yoshida T., Miyazawa T., Koyanagi Y. Retrovirology 6:53-53(2009) · Mapped (2) |
| Relaxin stimulates interleukin-6 and interleukin-8 secretion from the extraplacental chorionic cytotrophoblast. Bryant-Greenwood G.D., Yamamoto S.Y., Sadowsky D.W., Gravett M.G., Novy M.J. Placenta 30:599-606(2009) · Mapped (9) |
| Progenitors of skeletal muscle satellite cells express the muscle determination gene, MyoD. Kanisicak O., Mendez J.J., Yamamoto S., Yamamoto M., Goldhamer D.J. Dev. Biol. 332:131-141(2009) · Mapped (2) |
| TRPM2 functions as a lysosomal Ca2+-release channel in beta cells. Lange I., Yamamoto S., Partida-Sanchez S., Mori Y., Fleig A., Penner R. Sci Signal 2:ra23-ra23(2009) · Mapped (8) |
| Sequoia regulates cell fate decisions in the external sensory organs of adult Drosophila. Andrews H.K., Giagtzoglou N., Yamamoto S., Schulze K.L., Bellen H.J. EMBO Rep. 10:636-641(2009) · Mapped (26) |
| Incipient allochronic speciation by climatic disruption of the reproductive period. Yamamoto S., Sota T. Proc. Biol. Sci. 276:2711-2719(2009) · UniProtKB (30) |
| Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle. Imamura M., Negoro H., Kanematsu A., Yamamoto S., Kimura Y., Nagane K., Yamasaki T., Kanatani I., Ito N., Tabata Y. et al. Am. J. Physiol. Renal Physiol. 297:F46-54(2009) · Mapped (3) |
| Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. Iwasaki M., Hamada G.S., Nishimoto I.N., Netto M.M., Motola J. Jr., Laginha F.M., Kasuga Y., Yokoyama S., Onuma H., Nishimura H. et al. Cancer Sci. 100:927-933(2009) · Mapped (59) |
| 6-mercaptopurine (6-MP) induces p53-mediated apoptosis of neural progenitor cells in the developing fetal rodent brain. Kanemitsu H., Yamauchi H., Komatsu M., Yamamoto S., Okazaki S., Uchida K., Nakayama H. Neurotoxicol Teratol 31:198-202(2009) · Mapped (17) |
| An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III. Sato Y., Isaji T., Tajiri M., Yoshida-Yamamoto S., Yoshinaka T., Somehara T., Fukuda T., Wada Y., Gu J. J. Biol. Chem. 284:11873-11881(2009) · Mapped (9) |
| Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Guerin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains. Seki M., Honda I., Fujita I., Yano I., Yamamoto S., Koyama A. Vaccine 27:1710-1716(2009) · UniProtKB (3,906) |
| The implementation of personalized treatment for osteoporosis. Mori S., Chiba Y., Yamamoto S., Hosoi T., Horiuchi T., Kamimiya F., Tamura Y., Araki A., Ito H. Nippon Ronen Igakkai Zasshi 45:655-659(2008) · Mapped (9) |
| A multifunctional reporter mouse line for Cre- and FLP-dependent lineage analysis. Yamamoto M., Shook N.A., Kanisicak O., Yamamoto S., Wosczyna M.N., Camp J.R., Goldhamer D.J. Genesis 47:107-114(2009) · Mapped (5) |
| Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance. Yamamoto S., Tsuda H., Honda K., Onozato K., Takano M., Tamai S., Imoto I., Inazawa J., Yamada T., Matsubara O. Mod. Pathol. 22:499-507(2009) · Mapped (5) |
| Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer. Ueda S., Kondoh N., Tsuda H., Yamamoto S., Asakawa H., Fukatsu K., Kobayashi T., Yamamoto J., Tamura K., Ishida J. et al. BMC Cancer 8:384-384(2008) · Mapped (2) |
| Human uterine NK cells interact with uterine macrophages via NKG2D upon stimulation with PAMPs. Basu S., Eriksson M., Pioli P.A., Conejo-Garcia J., Mselle T.F., Yamamoto S., Wira C.R., Sentman C.L. Am. J. Reprod. Immunol. 61:52-61(2009) · Mapped (3) |
| FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. Nishio M., Endo T., Fujimoto K., Yamamoto S., Obara M., Yamaguchi K., Takeda Y., Goto H., Kasahara I., Sato N. et al. Eur. J. Haematol. 82:143-147(2009) · Mapped (4) |
| Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis. Koga Y., Yasunaga M., Moriya Y., Akasu T., Fujita S., Yamamoto S., Kozu T., Baba H., Matsumura Y. Cancer Sci. 99:1977-1983(2008) · Mapped (41) |
| Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Shiraishi K., Kohno T., Kunitoh H., Watanabe S., Goto K., Nishiwaki Y., Shimada Y., Hirose H., Saito I., Kuchiba A. et al. Carcinogenesis 30:65-70(2009) · Mapped (3) |
| Raloxifene reduces circulating levels of interleukin-7 and monocyte chemoattractant protein-1 in postmenopausal women. Yasui T., Uemura H., Hyodo S., Yamada M., Yamamoto S., Maegawa M., Tsuchiya N., Noguchi M., Yuzurihara M., Kase Y. et al. Atherosclerosis 204:471-475(2009) · Mapped (11) |
| EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan. Takano T., Fukui T., Ohe Y., Tsuta K., Yamamoto S., Nokihara H., Yamamoto N., Sekine I., Kunitoh H., Furuta K. et al. J. Clin. Oncol. 26:5589-5595(2008) · Mapped (15) |
| Enhanced CCL26 production by IL-4 through IFN-gamma-induced upregulation of type 1 IL-4 receptor in keratinocytes. Nishi N., Yamamoto S., Ou W., Muro E., Inada Y., Hamasaki Y. Biochem. Biophys. Res. Commun. 376:234-240(2008) · Mapped (7) |
